Literature DB >> 22472916

Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs.

Yoko Ibuka1,2, A David Paltiel1, Alison P Galvani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22472916      PMCID： PMC3570235          DOI： 10.1177/0272989X12441397

Source DB:  PubMed          Journal:  Med Decis Making        ISSN： 0272-989X            Impact factor:   2.583


× No keyword cloud information.
  26 in total

1.  Accounting for the cost of scaling-up health interventions.

Authors:  Benjamin Johns; Rob Baltussen
Journal:  Health Econ       Date:  2004-11       Impact factor: 3.046

2.  Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.

Authors:  Michael B Rothberg; David N Rose
Journal:  Am J Med       Date:  2005-01       Impact factor: 4.965

3.  Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination.

Authors:  Roberto Pradas-Velasco; Fernando Antoñanzas-Villar; María Puy Martínez-Zárate
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Seasonal influenza in the United States, France, and Australia: transmission and prospects for control.

Authors:  G Chowell; M A Miller; C Viboud
Journal:  Epidemiol Infect       Date:  2007-07-18       Impact factor: 2.451

Review 5.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.

Authors:  Lisa A Prosser; Megan A O'Brien; Noelle-Angelique M Molinari; Katherine H Hohman; Kristin L Nichol; Mark L Messonnier; Tracy A Lieu
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.

Authors:  Adam Lloyd; Nishma Patel; David A Scott; Claus Runge; Christa Claes; Markus Rose
Journal:  Eur J Health Econ       Date:  2007-03-02

Review 8.  The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

Authors:  Daniel J Isaacman; David R Strutton; Edward A Kalpas; Nathalie Horowicz-Mehler; Lee S Stern; Roman Casciano; Vincent Ciuryla
Journal:  Clin Ther       Date:  2008-02       Impact factor: 3.393

9.  The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.

Authors:  D A Turner; A J Wailoo; N J Cooper; A J Sutton; K R Abrams; K G Nicholson
Journal:  Vaccine       Date:  2005-09-06       Impact factor: 3.641

10.  Health benefits, risks, and cost-effectiveness of influenza vaccination of children.

Authors:  Lisa A Prosser; Carolyn Buxton Bridges; Timothy M Uyeki; Virginia L Hinrichsen; Martin I Meltzer; Noelle-Angelique M Molinari; Benjamin Schwartz; William W Thompson; Keiji Fukuda; Tracy A Lieu
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883
View more
  3 in total

1.  Dengue dynamics and vaccine cost-effectiveness in Brazil.

Authors:  David P Durham; Martial L Ndeffo Mbah; Jan Medlock; Paula M Luz; Lauren A Meyers; A David Paltiel; Alison P Galvani
Journal:  Vaccine       Date:  2013-06-20       Impact factor: 3.641

2.  Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.

Authors:  Martial L Ndeffo-Mbah; Vivian S Vigliotti; Laura A Skrip; Kate Dolan; Alison P Galvani
Journal:  Epidemiol Rev       Date:  2018-06-01       Impact factor: 6.222

Review 3.  Cost-Effectiveness Analysis in Implementation Science: a Research Agenda and Call for Wider Application.

Authors:  Emanuel Krebs; Bohdan Nosyk
Journal:  Curr HIV/AIDS Rep       Date:  2021-03-20       Impact factor: 5.495
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.